All Articles

Patient navigators are increasingly recognized for their critical role in helping patients make their way through complex healthcare systems, all the way from screening to treatment adherence. Clinical trials are a vital part of high-quality cancer care, and navigators have become invaluable in facilitating patient awareness and access to trials, while also normalizing the clinical trial process and dispelling myths.
Read More

The majority of patients with cancer will undergo surgery at some point during their treatment. Cancer surgery comes with a host of side effects, but integrative medicine, which combines conventional with complementary and alternative medicines, works to facilitate the body's innate healing response. It can minimize the side effects of anesthesia and surgery; enhance perioperative safety, comfort, and recovery; and give patients an improved sense of well-being during a particularly vulnerable time, according to Rosanne Sheinberg, MD, Assistant Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine in Baltimore, MD.
Read More

The next phase of the AONN+ Metrics study is designed to evaluate common barriers and challenges navigation programs encounter during the implementation of the metrics.
Read More


Poor implementation of survivorship care plans ultimately limits the ability to determine whether or not they work, according to Sarah A. Birken, PhD, Assistant Professor in the Department of Health Policy and Management at the University of North Carolina Chapel Hill.
Read More

An educational survivorship workshop increased knowledge and confidence levels and demonstrated educational merit in a group of primary care providers (PCPs), according to research presented by Genevieve Chaput, MD, at the ASCO Cancer Survivorship Symposium.
Read More


Best Practices in Oncology Biomarker Testing
Drs. Goeffrey Oxnard and Lauren Ritterhouse review the best practices to improve efficiencies in biomarker testing, including effective communication among the healthcare team, the pathologist, and the patient, as well as expediting processing in the pathology laboratory.
Read More

Creating a Paradigm for Biomarker Testing
Drs. Goeffrey Oxnard and Lauren Ritterhouse consider the advantages and disadvantages of liquid biopsies as an early screening tool for biomarker testing, and how to integrate various approaches into a biomarker testing paradigm.
Read More

The Role of Tumor Mutational Burden in Lung Cancer
Drs. Goeffrey Oxnard and Lauren Ritterhouse discuss the need for validation and standardization of Tumor Mutational Burden to make it a robust biomarker, in conjunction with PD-L1, in selecting immunotherapy for their lung cancer patients.
Read More

Page 200 of 283

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country